These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 27516139)

  • 41. Bathing With 2% Chlorhexidine Gluconate: Evidence and Costs Associated With Central Line-Associated Bloodstream Infections.
    Shah HN; Schwartz JL; Luna G; Cullen DL
    Crit Care Nurs Q; 2016; 39(1):42-50. PubMed ID: 26633158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chlorhexidine gluconate transparent dressing does not decrease central line-associated bloodstream infection in critically ill patients: A randomized controlled trial.
    Yu K; Lu M; Meng Y; Zhao Y; Li Z
    Int J Nurs Pract; 2019 Dec; 25(6):e12776. PubMed ID: 31631496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of Bloodstream Infections in Patients Undergoing Hemodialysis.
    Fisher M; Golestaneh L; Allon M; Abreo K; Mokrzycki MH
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):132-151. PubMed ID: 31806658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk of catheter-related bloodstream infection in elderly patients on hemodialysis.
    Murea M; James KM; Russell GB; Byrum GV; Yates JE; Tuttle NS; Bleyer AJ; Burkart JM; Freedman BI
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):764-70. PubMed ID: 24651074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Catheter-related bloodstream infection by Rhizobium radiobacter in a hemodialysis patient.
    Mandolfo S; Maggio M; Ronga C; Anesi A; Rognoni V
    J Vasc Access; 2018 Sep; 19(5):507-508. PubMed ID: 29542380
    [No Abstract]   [Full Text] [Related]  

  • 46. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
    Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
    BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study.
    Levy I; Katz J; Solter E; Samra Z; Vidne B; Birk E; Ashkenazi S; Dagan O
    Pediatr Infect Dis J; 2005 Aug; 24(8):676-9. PubMed ID: 16094219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are early cannulation arteriovenous grafts (ecAVG) a viable alternative to tunnelled central venous catheters (TCVCs)? An observational "virtual study" and budget impact analysis.
    Aitken E; Iqbal K; Thomson P; Kasthuri R; Kingsmore D
    J Vasc Access; 2016 May; 17(3):220-8. PubMed ID: 27032450
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
    Goudet V; Timsit JF; Lucet JC; Lepape A; Balayn D; Seguin S; Mimoz O
    Trials; 2013 Apr; 14():114. PubMed ID: 23782845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial.
    Ruschulte H; Franke M; Gastmeier P; Zenz S; Mahr KH; Buchholz S; Hertenstein B; Hecker H; Piepenbrock S
    Ann Hematol; 2009 Mar; 88(3):267-72. PubMed ID: 18679683
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of streptokinase for restoration of patency to hemodialysis central venous catheters: a low-cost, safe and effective option.
    Bashardoust B; Habibzadeh S; Sharghi A; Eskandari R; Maleki N
    J Vasc Access; 2017 Sep; 18(5):e70. PubMed ID: 28777422
    [No Abstract]   [Full Text] [Related]  

  • 52. Antimicrobial Activity of a Novel Vascular Access Film Dressing Containing Chlorhexidine Gluconate.
    Wibaux A; Thota P; Mastej J; Prince DL; Carty N; Johnson P
    PLoS One; 2015; 10(11):e0143035. PubMed ID: 26599087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pantoea agglomerans as a rare cause of catheter-related infection in hemodialysis patients.
    Wong KW
    J Vasc Access; 2013; 14(3):306. PubMed ID: 23599132
    [No Abstract]   [Full Text] [Related]  

  • 54. Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care.
    Mitchell ML; Ullman AJ; Takashima M; Davis C; Mihala G; Powell M; Gibson V; Zhang L; Bauer M; Geoffrey Playford E; Rickard CM
    Aust Crit Care; 2020 Sep; 33(5):441-451. PubMed ID: 31757717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections.
    Suwantarat N; Carroll KC; Tekle T; Ross T; Maragakis LL; Cosgrove SE; Milstone AM
    Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1183-6. PubMed ID: 25111928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of chlorhexidine dressings to prevent catheter-related bloodstream infections. Does one size fit all? A systematic literature review and meta-analysis.
    Puig-Asensio M; Marra AR; Childs CA; Kukla ME; Perencevich EN; Schweizer ML
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1388-1395. PubMed ID: 32935659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study.
    Htay H; Choo JCJ; Johnson DW; Pascoe EM; Jayaballa M; Oei EL; Ng LC; Wu SY; Foo MWY
    Int Urol Nephrol; 2021 Apr; 53(4):803-812. PubMed ID: 33025409
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maintenance antisepsis in reducing the rate of late-onset central venous catheter-related bloodstream infection: A comparison of 0.05% and 1% chlorhexidine.
    Kikuchi M; Sato T; Okada S; Abe N; Sato A; Suzuki Y
    J Infect Chemother; 2020 Feb; 26(2):188-193. PubMed ID: 31495567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial activity of a chlorhexidine intravascular catheter site gel dressing.
    Karpanen TJ; Casey AL; Conway BR; Lambert PA; Elliott TS
    J Antimicrob Chemother; 2011 Aug; 66(8):1777-84. PubMed ID: 21609979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Catheter-related bloodstream infections in a nephrology unit: Analysis of patient- and catheter-associated risk factors.
    Zanoni F; Pavone L; Binda V; Tripepi G; D'Arrigo G; Scalamogna A; Messa P
    J Vasc Access; 2021 May; 22(3):337-343. PubMed ID: 32648807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.